Fatty liver markers before weight-loss surgery
Treatments studied
Part of Digestive system, Hormones & metabolism clinical trials.
This study looks at special markers in the blood to better understand and predict a fatty liver condition called NAFLD. It focuses on people who are very overweight and are already planning to have weight-loss surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a body mass index (BMI) over 35.
- You must be scheduled for bariatric (weight-loss) surgery based on international guidelines.
- You cannot have an active viral liver infection, like hepatitis B or C.
- You cannot have an alcohol or drug addiction.
- You must be able to understand and agree to the study on your own.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects information about metabolic and unexplained (cryptogenic) liver disease and looks at “omics” tests, which are lab tests that measure patterns in blood or tissue to learn what drives the disease. It may help researchers better understand fatty liver and related serious complications, like liver scarring and liver cancer.
This study uses multiple types of health data (“multi-omics”) to help choose a personalized treatment plan for people with obesity-related fatty liver disease. It may help match treatment to your biology to improve outcomes.
This study looks at how fat build-up in the liver relates to metabolism in people who are scheduled for weight-loss (bariatric) surgery. By doing special blood tests and MRI scans, researchers hope to better understand liver health and improve care.
This study looks at whether certain blood markers—including inflammation and fat levels—can help predict scarring in fatty livers. Understanding this connection may help doctors better identify patients at risk for serious liver damage.
This trial looks at whether weight-loss (bariatric) surgery helps people with fatty liver disease, including “NASH,” and related liver scarring. If you have obesity and a confirmed liver fat diagnosis (and for NASH, biopsy-proven NASH with some fibrosis), the study may follow your outcomes after surgery.
This study looks at people with fatty liver disease and common health issues like obesity, diabetes, high blood pressure, or abnormal cholesterol. It may help researchers understand how liver fat and heart/metabolism problems relate and how they affect health over time.
Hear when a new NAFLD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.